Paasa Logo
State Street SPDR S&P Pharmaceuticals ETF logo
XPHAMEXMarket openCloses 4:00pm ET

State Street SPDR S&P Pharmaceuticals ETF

$66.20Last updated
-$0.20 (0.30%)Past day
Timezone

State Street SPDR S&P Pharmaceuticals ETF (AMEX: XPH) is an exchange-traded fund listed on NYSE Arca, trading at $66.20 (about ₹6,357 a unit) as of 25 Sep 2026, 2:12 PM ET. It has an expense ratio of 0.35% and holds 62 securities. Indian residents can buy XPH through Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$66.63
Previous close:$66.40
Volume:37.25K

Today's low

$65.70

Today's high

$66.69

52 week low

$46.24

52 week high

$74.35

XPH opened at $66.63, closed previously at $66.40, and has traded between $46.24 and $74.35 over the past 52 weeks.

About

SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.

Issuer
SPDR
Exchange listed on
AMEX
Asset class
Equity
Base currency
USD
Domicile
United States
Dividends
Distributing
Launched
2006
ISIN
US78464A7220

Key statistics

Expense ratio

0.35%

Assets (AUM)

$547.0M

Holdings

62

NAV

$66.30

Avg. volume

—

1-year price change

+42.18%

5-year price change

+36.10%

Price change excludes dividends.

Top 10 holdings

1. VERADERMICS INC
2.3%
2. XERIS BIOPHARMA HOLDINGS INC
2.2%
3. AMNEAL PHARMACEUTICALS INC
2.2%
4. OMEROS CORP
2.1%
5. ANI PHARMACEUTICALS INC
2.1%
6. VIATRIS INC
2.0%
7. LIGAND PHARMACEUTICALS
2.0%
8. INDIVIOR PHARMACEUTICALS INC
2.0%
9. SUPERNUS PHARMACEUTICALS INC
2.0%
10. ELI LILLY + CO
2.0%

XPH holds 62 securities in total. These 10 are 20.9% of the fund.

Where the money is invested

Countries

United States
96.2%
Ireland
3.8%
Other
0.1%

How to buy XPH from India

Indian residents can buy XPH units through Paasa in three steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the units are held in your own name with Interactive Brokers.

  1. Open your Paasa account

    KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds from your Indian bank account

    Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.

  3. Search XPH and buy

    Find the fund by its ticker, XPH, on NYSE Arca, and place your order. Fractional units are available and there is no minimum trade size, so you can buy by amount.

Read the full guide: how to invest in XPH from India

Trading and taxes when buying XPH from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation. Gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateIt pays the dividends from its holdings out to you in cash, and dividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Units are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

What is the XPH price today?

State Street SPDR S&P Pharmaceuticals ETF (XPH) last traded at $66.20 on NYSE Arca, as of 25 Sep 2026, 2:12 PM ET. That is ₹6,357 a unit at the 24 Sep 2026 USD/INR rate.

When does XPH trade, in Indian time?

NYSE Arca trades 7:00 pm – 1:30 am IST, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

How big is XPH, and what does it cost to hold?

State Street SPDR S&P Pharmaceuticals ETF manages about $547.0M. Its expense ratio is 0.35% a year, deducted inside the fund. It launched in 2006.

What are XPH's largest holdings?

The top three are VERADERMICS INC (2.3%), XERIS BIOPHARMA HOLDINGS INC (2.2%) and AMNEAL PHARMACEUTICALS INC (2.2%). XPH's 10 largest positions make up 20.9% of the fund.

Does XPH pay dividends?

Yes. XPH is a distributing fund and pays the dividends from its holdings out in cash. In India they are taxed at your slab rate. The US withholds 25% tax on dividends before they reach you; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit when you file in India.

How are gains on XPH taxed in India?

Units held for more than 24 months are long-term and taxed at 12.5% without indexation; units held for 24 months or less are taxed at your income-tax slab rate. The gain is worked out in rupees, so the currency move counts.

Can I buy fractional units of XPH?

Yes. You can buy XPH by amount rather than by whole unit, and there is no minimum trade size.

How has XPH performed?

XPH's price is up 42.2% over the past year and up 36.1% over five years. These figures are price change only and exclude dividends; past performance does not guarantee future returns.